chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Alpha 1 foetoprotein normal, Anaemia, Apgar score normal, Blood glucose normal, Drug exposure during pregnancy
Clinical narrative: Information has been received from a nurse practitioner for the pregnancy registry for GARDASIL vaccine concerning a 27 year old female with a history of 5 pregnancies and 4 live births and no pertinent medical history and no allergies who on 28-JAN-2008 was vaccinated with a first dose of GARDASIL vaccine 0.5 ml (lot # 655327/1287U). Other medication used during pregnancy included pre-natal vitamins, ZOFRAN ODT 8mg PRN for nausea (previously reported as vomiting), FERROUS SULFATE 325 mg daily for anemia and MACROBID 100 mg BID for UTI. There were no birth defects and no infant complications in previous pregnancies. The patient became pregnant after vaccination "34 weeks" ago. The date of last menstrual period was 11-FEB-2008. The estimated due date is 17-NOV-2008. The patient sought medical attention seen at the practice. The routine pregnancy work up was performed. On 31-MAR-2008 the ultrasound was performed. On 02-JUN-2008 MSAFF was performed with normal limits. Follow-up information was received from pregnancy questionnaire. On 10-MAR-2008 the routine pregnancy labs were performed within normal limits. On 29-JUL-2008 the glucose test was performed within normal limits. On 29-JUL-2008 the whole blood hematocrit ad blood hemoglobin test were performed with the results of mild anemia. On 14-OCT-2008 the vaginal Streptococcus group B culture test was performed with negative results. On 02-NOV-2008 the patient with 1 spontaneous abortion (incomplete abortion D&C done) delivered a male health baby weighing 7 pounds 6 ounces with apgar score 9/10 at 38 weeks. There was no congenital anomalies or other complication or abnormalities. There was no complication during pregnancy and delivery. Additional information is not expected.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Haematocrit abnormal, Haemoglobin abnormal, Laboratory test normal, Streptococcal identification test negative, Ultrasound scan normal
Clinical narrative: Information has been received from a nurse practitioner for the pregnancy registry for GARDASIL vaccine concerning a 27 year old female with a history of 5 pregnancies and 4 live births and no pertinent medical history and no allergies who on 28-JAN-2008 was vaccinated with a first dose of GARDASIL vaccine 0.5 ml (lot # 655327/1287U). Other medication used during pregnancy included pre-natal vitamins, ZOFRAN ODT 8mg PRN for nausea (previously reported as vomiting), FERROUS SULFATE 325 mg daily for anemia and MACROBID 100 mg BID for UTI. There were no birth defects and no infant complications in previous pregnancies. The patient became pregnant after vaccination "34 weeks" ago. The date of last menstrual period was 11-FEB-2008. The estimated due date is 17-NOV-2008. The patient sought medical attention seen at the practice. The routine pregnancy work up was performed. On 31-MAR-2008 the ultrasound was performed. On 02-JUN-2008 MSAFF was performed with normal limits. Follow-up information was received from pregnancy questionnaire. On 10-MAR-2008 the routine pregnancy labs were performed within normal limits. On 29-JUL-2008 the glucose test was performed within normal limits. On 29-JUL-2008 the whole blood hematocrit ad blood hemoglobin test were performed with the results of mild anemia. On 14-OCT-2008 the vaginal Streptococcus group B culture test was performed with negative results. On 02-NOV-2008 the patient with 1 spontaneous abortion (incomplete abortion D&C done) delivered a male health baby weighing 7 pounds 6 ounces with apgar score 9/10 at 38 weeks. There was no congenital anomalies or other complication or abnormalities. There was no complication during pregnancy and delivery. Additional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Gestational diabetes, Ultrasound antenatal screen normal
Clinical narrative: Initial and follow up information has been received from a nurse, for the pregnancy for GARDASIL, concerning a black female with one previous pregnancy and one full term delivery with no birth defects who was vaccinated with a 1st dose of GARDASIL when she was 5 weeks pregnant (previously reported as 16 weeks gestation on 11-Jun-2008) with LMP of 04-Mar-2008 (previously reported as approximately 15-Feb-2008). Other therapies included prenatal vitamins (unspecified). No adverse events reported. On 14-May-2008 the patient had a routine ultrasound, results indicated that the dating was 9w6D and estimated delivery date was 11-Dec-2008. The patient outcome was not reported. Additional information has been requested. Follow up information has been received from a complete pregnancy questionnaire on 30-Dec-2008 for the pregnancy registry for GARDASIL, concerning a black female patient with one previous pregnancy, no pertinent medical history and no known allergies who on an unspecified date was vaccinated with a dose of GARDASIL when she was 5 weeks pregnant (LMP: 04-Mar-2008). On 14-May-2008 the patient had a routine ultrasound, results indicated the age of the fetus was 9 weeks and 6 days and on 19-Nov-2008 the patient delivered a normal infant. In the following up information received on 30-Dec-2008 contained the following adverse experiences: gestational diabetes mellitus which was treated with Metformin (500-750 mg daily). No further information is available.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Alpha 1 foetoprotein normal, Drug exposure during pregnancy, Glucose tolerance test abnormal, Laboratory test normal, Nasopharyngitis
Clinical narrative: Information has been received through the Merck pregnancy registry from a female consumer, nurse practitioner and physician concerning female with history of caesarian delivery and abnormal past papanicolaou test and none known drug reactions / allergies, who on 22-Feb-2008 (also reported as 22-June-2008 was vaccinated intramuscularly, into left deltoid, with her 0.5ml first dose of GARDASIL (lot # 655327/128U) and found out she was pregnant (LMP) 26-Jan-2008, (also reported as 28-June-2008) . On 29-Feb-2008, the patient took pregnancy test that tested positive. The urine test for pregnancy was confirmed during the physician's office visit on 03-Mar-2008. Unspecified medical attention was sought during an office visit. No adverse symptoms. No further information was provided. Follow up information was received via pregnancy questionnaire from a physician. The patient had a history of early tobacco and discontinued with pregnancy. She had one previous pregnancy which was full term delivery and the infant complication was macrosomia. There was no other significant past medical history and concurrent medical conditions. During this pregnancy she took MACROBID 100mg bid and Phenazopyridine  hydrochloride 200mg tid to treat urinary tract infection and pseudo ephedrine HCL 300mg prn tid to treat cold / congestion. Concomitant medication included multivitamins. Diagnostic test during the pregnancy included : cystic fibrosis on 16-APR-2008 was negative, serum alpha-fetoprotein test on 16-May-2008 was negative, ultrasound on 12-Jun-2008 CWO normal anatomy, and glucose tolerance test on 16-Sep-2008 was 1/4 elevated. On 23-Oct-2008, she delivery a normal health male baby weighting 3129 grams, length 48cm, and Apgar score was 9/9 at 39 weeks from her LMP. Additional information is not expected.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Pregnancy test positive, Respiratory tract congestion, Ultrasound scan normal, Urinary tract infection
Clinical narrative: Information has been received through the Merck pregnancy registry from a female consumer, nurse practitioner and physician concerning female with history of caesarian delivery and abnormal past papanicolaou test and none known drug reactions / allergies, who on 22-Feb-2008 (also reported as 22-June-2008 was vaccinated intramuscularly, into left deltoid, with her 0.5ml first dose of GARDASIL (lot # 655327/128U) and found out she was pregnant (LMP) 26-Jan-2008, (also reported as 28-June-2008) . On 29-Feb-2008, the patient took pregnancy test that tested positive. The urine test for pregnancy was confirmed during the physician's office visit on 03-Mar-2008. Unspecified medical attention was sought during an office visit. No adverse symptoms. No further information was provided. Follow up information was received via pregnancy questionnaire from a physician. The patient had a history of early tobacco and discontinued with pregnancy. She had one previous pregnancy which was full term delivery and the infant complication was macrosomia. There was no other significant past medical history and concurrent medical conditions. During this pregnancy she took MACROBID 100mg bid and Phenazopyridine  hydrochloride 200mg tid to treat urinary tract infection and pseudo ephedrine HCL 300mg prn tid to treat cold / congestion. Concomitant medication included multivitamins. Diagnostic test during the pregnancy included : cystic fibrosis on 16-APR-2008 was negative, serum alpha-fetoprotein test on 16-May-2008 was negative, ultrasound on 12-Jun-2008 CWO normal anatomy, and glucose tolerance test on 16-Sep-2008 was 1/4 elevated. On 23-Oct-2008, she delivery a normal health male baby weighting 3129 grams, length 48cm, and Apgar score was 9/9 at 39 weeks from her LMP. Additional information is not expected.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Anxiety, Apgar score normal, Drug exposure during pregnancy, Haemorrhage, Muscle spasms
Clinical narrative: Information has been received from Pregnancy Registry for GARDASIL vaccine from a Registered Nurse (R.N.) concerning a female patient who was vaccinated with a third dose of GARDASIL vaccine (lot # unknown).  The nurse reported that the patient received her third injection when she was pregnant but did not know it.  It was unknown if medical attention was sought by the patient.  The data of last menstrual period and estimated date of delivery is unknown.  The outcome was unknown.  Follow up information has been received from a registered nurse, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old Caucasian female patient with no previous pregnancy history and no pertinent medical history who on 09-OCT-2007 was vaccinated with the first dose of GARDASIL (lot # not provided).  Subsequently the patient was pregnant (LMP was 13-NOV-2007 and EDD was 20-AUG-2008).  On 10-DEC-2007 she received the second dose of GARDASIL (lot # not provided) when she did not realize she was pregnant (previously reported the third dose).  Concomitant therapy included allergy injection every other week for treatment of allergies.  Other medications used during pregnancy included prenatal vitamin qd taken for December 2007 to August 2008.  In October 2007, the patient experienced anxiety and ZOLOFT 50 mg qd was started.  On 14-JAN-2008 ultrasound was performed for bleeding and cramping with the result of within normal limits.  On 24-MAR-2008 routine ultrasound was performed again with the result of within normal limits.  On 06-AUG-2008 (from LMP 37 weeks 6 days) the patient delivered a normal, healthy male baby weighting 8 pounds 10 ounces with no congenital anomalies.  The Apgar score was 8/9.  There was not complication during pregnancy and labor/delivery, and not infections or illness during pregnancy for the patient. Additional information is not expected.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Ultrasound scan normal
Clinical narrative: Information has been received from Pregnancy Registry for GARDASIL vaccine from a Registered Nurse (R.N.) concerning a female patient who was vaccinated with a third dose of GARDASIL vaccine (lot # unknown).  The nurse reported that the patient received her third injection when she was pregnant but did not know it.  It was unknown if medical attention was sought by the patient.  The data of last menstrual period and estimated date of delivery is unknown.  The outcome was unknown.  Follow up information has been received from a registered nurse, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old Caucasian female patient with no previous pregnancy history and no pertinent medical history who on 09-OCT-2007 was vaccinated with the first dose of GARDASIL (lot # not provided).  Subsequently the patient was pregnant (LMP was 13-NOV-2007 and EDD was 20-AUG-2008).  On 10-DEC-2007 she received the second dose of GARDASIL (lot # not provided) when she did not realize she was pregnant (previously reported the third dose).  Concomitant therapy included allergy injection every other week for treatment of allergies.  Other medications used during pregnancy included prenatal vitamin qd taken for December 2007 to August 2008.  In October 2007, the patient experienced anxiety and ZOLOFT 50 mg qd was started.  On 14-JAN-2008 ultrasound was performed for bleeding and cramping with the result of within normal limits.  On 24-MAR-2008 routine ultrasound was performed again with the result of within normal limits.  On 06-AUG-2008 (from LMP 37 weeks 6 days) the patient delivered a normal, healthy male baby weighting 8 pounds 10 ounces with no congenital anomalies.  The Apgar score was 8/9.  There was not complication during pregnancy and labor/delivery, and not infections or illness during pregnancy for the patient. Additional information is not expected.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Haematology test, Labour induction, Prolonged pregnancy
Clinical narrative: Information has been received through the Merck pregnancy registry from a physician concerning a 25 year old female with a history of tonsillectomy who on 29-NOV-2007 was vaccinated with the third dose of GARDASIL.  No information was provided concerning the first or second dose of GARDASIL.  On 29-NOV-2007 the patient also had blood work taken "which had showed she was pregnant" (LMP=05-SEP-2007).  The patient sought unspecified medical attention and reported that she was about "three weeks pregnant".  No further information was provided.  Follow-up information has been received from a physician concerning the patient who was induced on 12-AUG-2008 because she was 41 weeks gestation, and had a vaginal delivery of a normal baby with "good Apgars", "everything went well".  The reporter indicated that the patient did well and was discharged home with the baby on the next day  No further information is available.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Autism, Body temperature increased, Childhood disintegrative disorder, Diarrhoea, Disturbance in social behaviour
Clinical narrative: Information has been received from an author of a published article, regarding a child who at 2 years of age received a dose of MMR II (date not reported) and approximately 18 months late was diagnosed with autism. The child was developing normally until she turned two years old. At that age, she received her MMR vaccine. Shortly thereafter, she developed a fever of 105 degrees that lasted one week. Her physician said she had a bad case of the flu; however, she suddenly stopped talking and interacting. She also began vomiting and developed diarrhea. Along with other symptoms, the diarrhea lasted 32 weeks, in July of 1997, 18 months after receiving her MMR, she was diagnosed with autism. Upon internal review, the event of autism was determined to be an other important medical event. No further information is available. A copy of the published literature article is attached as further documentation of the patient's experience.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Influenza, Pyrexia, Speech disorder developmental, Vomiting
Clinical narrative: Information has been received from an author of a published article, regarding a child who at 2 years of age received a dose of MMR II (date not reported) and approximately 18 months late was diagnosed with autism. The child was developing normally until she turned two years old. At that age, she received her MMR vaccine. Shortly thereafter, she developed a fever of 105 degrees that lasted one week. Her physician said she had a bad case of the flu; however, she suddenly stopped talking and interacting. She also began vomiting and developed diarrhea. Along with other symptoms, the diarrhea lasted 32 weeks, in July of 1997, 18 months after receiving her MMR, she was diagnosed with autism. Upon internal review, the event of autism was determined to be an other important medical event. No further information is available. A copy of the published literature article is attached as further documentation of the patient's experience.
Age: 0.3
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Appendicectomy, Computerised tomogram abnormal, Explorative laparotomy, Intussusception, Small intestinal obstruction
Clinical narrative: Information has been received on request from the FDA regarding a less than 6 month old male who in May 2008, was vaccinated with ROTATEQ. Subsequently the patient experienced intussusception, went to the Emergency Room and was hospitalized. It was reported that the patient recovered from intussusception. Additional information was obtained on request by the Company from the FDA. It was reported that a 4 month old female who on 28-MAY-2008 was vaccinated with the second dose of ROTATEQ (lot #: 660286/1830U). Vaccine received at same date included the second dose of PEDIARIX (lot #: AC21B127AA) IM into the right leg, the second dose of of ACTHIB (lot #: UF231AA) IM into the left leg and the second dose of PREVNAR (lot #: C49918) IM into the left leg. ON 20-JUN-2008 the patient presented to the ER and was admitted for 3 days. The patient was previously seen by primary doctor. The patient was admitted by the service for IV fluids, was found to have intussusception via CT scan, had exploratory laparotomy with reduction of intussusception, appendectomy and small bowel obstruction. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Intussusception was considered to be immediately life-threatening. The original reporting source was not provided. The VAERS ID # is 318218 and 23312. No further information is available.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal discomfort, Antinuclear antibody negative, Autopsy, Cardiac enzymes increased, Catheterisation cardiac normal
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Chest discomfort, Coxsackie virus serology test negative, Death, Dizziness, Dyspnoea
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Echovirus serology test negative, General physical health deterioration, Hypoaesthesia, Hypoperfusion, Influenza serology negative
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Myocarditis, Nausea, Polymerase chain reaction, Streptococcal identification test positive, Surgery
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Ventricular tachycardia, Virus serology test
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal pain upper, Carditis, Death, Dyspnoea, Hypoaesthesia
Clinical narrative: On July 31st, she had complaints of stomach pains. She took Pepto Bismol. The coming Saturday her left arm became numb. On Sunday afternoon around 1PM she couldn't breathe and we took her to the emergency room. Shortly after one of her legs became numb too so she was placed in a wheelchair. She passed away the following morning at 1:15AM on 8/4/08.
Sex: M
Vaccine: TDAP
Symptoms: Allergy test, Pruritus, Urticaria
Clinical narrative: Child developed rash (urticaria) the 2nd day of administration, on back, lower ext. buttocks. Positive pruritic. Txt on the 3rd day in Clinic SOLUMEDROL 40mg IM x one, ATARAX 25mg every 6 hours. BENADRYL 50mg IM, next day PRELONE 20mg bid x 5 d.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Chelation therapy, Drug toxicity, Neurological symptom, Surgery
Clinical narrative: Information has been received from a physician via e-mail concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL. "After receiving GARDASIL", the patient experienced neurological symptoms, possible seizures and toxic poisoning and was hospitalized. It was reported that the patient "had to undergo chelation and a surgery". The outcome of the patient was not reported. The reporter considered the patient's events to be other important medical events due to the surgery. No further information is available.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Activities of daily living impaired, Asthenia, Blood iron increased, Blood pressure decreased, Chelation therapy
Clinical narrative: Information has been received from a physician via e-mail concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL. "After receiving GARDASIL", the patient experienced neurological symptoms, possible seizures and toxic poisoning and was hospitalized. It was reported that the patient "had to undergo chelation and a surgery". The outcome of the patient was not reported. The reporter considered the patient's events to be other important medical events due to the surgery. No further information is available.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Convulsion, Dizziness, Eating disorder, Fluid replacement, Gastric disorder
Clinical narrative: Information has been received from a physician via e-mail concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL. "After receiving GARDASIL", the patient experienced neurological symptoms, possible seizures and toxic poisoning and was hospitalized. It was reported that the patient "had to undergo chelation and a surgery". The outcome of the patient was not reported. The reporter considered the patient's events to be other important medical events due to the surgery. No further information is available.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Headache, Hyperbaric oxygen therapy, Loss of consciousness, Neurological symptom, Oxygen supplementation
Clinical narrative: Information has been received from a physician via e-mail concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL. "After receiving GARDASIL", the patient experienced neurological symptoms, possible seizures and toxic poisoning and was hospitalized. It was reported that the patient "had to undergo chelation and a surgery". The outcome of the patient was not reported. The reporter considered the patient's events to be other important medical events due to the surgery. No further information is available.
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Sinus disorder, Tremor, Weight decreased
Clinical narrative: Information has been received from a physician via e-mail concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL. "After receiving GARDASIL", the patient experienced neurological symptoms, possible seizures and toxic poisoning and was hospitalized. It was reported that the patient "had to undergo chelation and a surgery". The outcome of the patient was not reported. The reporter considered the patient's events to be other important medical events due to the surgery. No further information is available.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, FLU3, HEPA, MMR, PNC
Symptoms: Injection site swelling
Clinical narrative: CHILD IN OFFICE ON 12/01/08 FOR 12 MONTH WELL CHECK.  HEPATITIS A, FLU, MMR AND PREVNAR GIVEN ON THIS DAY.  THE FLU AND HEPATITIS VACCINES WERE GIVEN ON THE RIGHT THIGH IM.  CHILD HAD AN OFFICE VISIT ON 12/06/08 AND THERE WAS NO MENTION OF AN ADVERSE REACTION ON THE LEG.  THERE WAS A PHONE CALL FROM MOM ON 12/08/08 AND SHE DID MENTION THAT THERE WAS A KNOT ON THE RIGHT THIGH.  ANOTHER CALL FROM MOM ON 12/12/08 ABOUT SINUS INFECTION AND MOM MENTIONED A KNOT ON RIGHT THIGH.  OFFICE VISIT ON 12/18/08 CHILD DIAGNOSED WITH AN ABCESS ON RIGHT THIGH AND WAS SENT TO THE EMERGENCY ROOM.  CHILD HAD SURGERY AT HOSPITAL ON 12/19/2008.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, FLU3, HEPA, MMR, PNC
Symptoms: Injection site abscess, Injection site nodule, Sinusitis, Surgery
Clinical narrative: CHILD IN OFFICE ON 12/01/08 FOR 12 MONTH WELL CHECK.  HEPATITIS A, FLU, MMR AND PREVNAR GIVEN ON THIS DAY.  THE FLU AND HEPATITIS VACCINES WERE GIVEN ON THE RIGHT THIGH IM.  CHILD HAD AN OFFICE VISIT ON 12/06/08 AND THERE WAS NO MENTION OF AN ADVERSE REACTION ON THE LEG.  THERE WAS A PHONE CALL FROM MOM ON 12/08/08 AND SHE DID MENTION THAT THERE WAS A KNOT ON THE RIGHT THIGH.  ANOTHER CALL FROM MOM ON 12/12/08 ABOUT SINUS INFECTION AND MOM MENTIONED A KNOT ON RIGHT THIGH.  OFFICE VISIT ON 12/18/08 CHILD DIAGNOSED WITH AN ABCESS ON RIGHT THIGH AND WAS SENT TO THE EMERGENCY ROOM.  CHILD HAD SURGERY AT HOSPITAL ON 12/19/2008.
Sex: F
Vaccine: PPV, PPV
Symptoms: Erythema, Oedema peripheral, Pain, Rash, Skin warm
Clinical narrative: 65 yo WF presented to clinic 2/17 for c/o weakness x 7-10 days. MD thought it could be viral syndrome. During this visit, pt was given Pneumovax in left deltoid. Several hours after vaccination, pt developed pain, redness swelling and itching in left arm. Treated pain with Tylenol until seen by MD 2/18 for symptoms. Erythema noted from deltoid down midway to elbow on assessment. Pt afebrile. VSS. Pain in Left arm: 3/10 (Numeric) Forearm is also warm. The skin is intact. Recommended diphenhydramine 50mg po q6h x 24hrs and ice to site PRN.
Sex: F
Vaccine: PPV, PPV
Symptoms: Asthenia, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: 65 yo WF presented to clinic 2/17 for c/o weakness x 7-10 days. MD thought it could be viral syndrome. During this visit, pt was given Pneumovax in left deltoid. Several hours after vaccination, pt developed pain, redness swelling and itching in left arm. Treated pain with Tylenol until seen by MD 2/18 for symptoms. Erythema noted from deltoid down midway to elbow on assessment. Pt afebrile. VSS. Pain in Left arm: 3/10 (Numeric) Forearm is also warm. The skin is intact. Recommended diphenhydramine 50mg po q6h x 24hrs and ice to site PRN.
Sex: F
Vaccine: PPV, PPV
Symptoms: Pain in extremity, Skin warm
Clinical narrative: 65 yo WF presented to clinic 2/17 for c/o weakness x 7-10 days. MD thought it could be viral syndrome. During this visit, pt was given Pneumovax in left deltoid. Several hours after vaccination, pt developed pain, redness swelling and itching in left arm. Treated pain with Tylenol until seen by MD 2/18 for symptoms. Erythema noted from deltoid down midway to elbow on assessment. Pt afebrile. VSS. Pain in Left arm: 3/10 (Numeric) Forearm is also warm. The skin is intact. Recommended diphenhydramine 50mg po q6h x 24hrs and ice to site PRN.
Age: 58.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Initial report received on 16 January 2009 from a health professional. A 58 year old female, with a history of hypertension, Hypercholesterolemia and an unspecified reaction to unspecified international travel medications, received an intramuscular left deltoid injection of FLUZONE (lot number U2769AA) on 20 November 2008 at 16:00 several hours after vaccination, at 18:00, injection site became red, raised and warm to touch. The area was the size of a 50 cent piece. Ice was applied to the area. Since 20 November 2008, the area sporadically becomes itchy. The patient scratches the area, it scabs over, heals, and then becomes itchy again. At the time of the report, the patient had not recovered.
Age: 58.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site scab, Injection site swelling, Injection site warmth
Clinical narrative: Initial report received on 16 January 2009 from a health professional. A 58 year old female, with a history of hypertension, Hypercholesterolemia and an unspecified reaction to unspecified international travel medications, received an intramuscular left deltoid injection of FLUZONE (lot number U2769AA) on 20 November 2008 at 16:00 several hours after vaccination, at 18:00, injection site became red, raised and warm to touch. The area was the size of a 50 cent piece. Ice was applied to the area. Since 20 November 2008, the area sporadically becomes itchy. The patient scratches the area, it scabs over, heals, and then becomes itchy again. At the time of the report, the patient had not recovered.
Age: 58.0
Sex: F
Vaccine: FLU3, FLU3, FLU3
Symptoms: No reaction on previous exposure to drug
Clinical narrative: Initial report received on 16 January 2009 from a health professional. A 58 year old female, with a history of hypertension, Hypercholesterolemia and an unspecified reaction to unspecified international travel medications, received an intramuscular left deltoid injection of FLUZONE (lot number U2769AA) on 20 November 2008 at 16:00 several hours after vaccination, at 18:00, injection site became red, raised and warm to touch. The area was the size of a 50 cent piece. Ice was applied to the area. Since 20 November 2008, the area sporadically becomes itchy. The patient scratches the area, it scabs over, heals, and then becomes itchy again. At the time of the report, the patient had not recovered.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Erythema, Rash generalised, Rash macular
Clinical narrative: 10 days after vaccinations, he developed a rash all over body (mostly on face & neck).  It was a red, blotchy rash with tiny raised bumps.  Rash lasted 3 days. No fever.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea, Rash
Clinical narrative: Rash, shortness of breath.  Rx- BENADRYL 25mg IV, SOLUMEDROL 125mg IV;  MEDROL DOSC Pack, BENADRYL PO- Symptoms resolved.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Ear pain, Herpes zoster, Oral herpes
Clinical narrative: Patient received vaccine 01/19/09 (Monday) and report ear ache and cold sores on 01/23/09. Patient treated as such but returned to MD office and diagnosed with shingles on 02/09/09. Patient presents with lesions on left lip and left ear.
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia, Muscular weakness, Pain in extremity, Radiculitis brachial, Urticaria
Clinical narrative: - Hives reported - symptoms of Brachial neuritis - R arm deep ache, weakness, numbness.
Age: 34.0
Sex: M
Vaccine: MMR, TDAP
Symptoms: Chills, Dizziness, Pain, Pyrexia
Clinical narrative: 102 degree fever, chills, body ache, dizziness lasted 36-48 hours
Age: 0.6
Sex: M
Vaccine: FLU3
Symptoms: Head titubation
Clinical narrative: Vaccine was given 1/30/09-same day Patient developed repetitive Head nodding 3-4 episodes per hour per parents. Observed 1 episode in clinic
Age: 45.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Skin plaque
Clinical narrative: 9 cm x 10 cm erythematous plaque, hot raised, at injection site, mild pruritis. Pt noted began after injection, enlarging qd
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Irritability
Clinical narrative: Quarter sized swelling @ injection site (upper quadrant of left thigh) 14 days post vaccination pain to the touch, cranky child. Redness present 4d. Post initial reaction still red @ site
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Immunisation reaction, Lymphadenopathy, Mass, Nuclear magnetic resonance imaging abnormal, Ultrasound scan abnormal
Clinical narrative: I had a tetanus shot in my right arm.  About 4 days later I noticed a lump on my right shoulder.  I had an ultrasound and that showed 3 lumps.  I had an MRI done & the Dr. said I had enlarged lymph nodes, which was a reaction to the tetanus shot.  Right now I have one swollen lymph node.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC
Symptoms: Hypotonia, Staring
Clinical narrative: Within 5-10 min of giving immunizations infant became limp 1 eyes appearing "vacant." No jerking motions/cyanosis - 1 Hr 150-O2 100% monitored for 45 degree - became more alert/responsive after 1/2 hr. Home with mom - instructed to monitor closely.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Feeling cold, Muscle spasticity, Musculoskeletal stiffness
Clinical narrative: Pt reported coldness, stiffness, chills, spasticity occurred 4 hrs after vaccine (flu). Episode lasted 5 minutes.
Age: 0.6
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Urticaria
Clinical narrative: Developed hives approximately 12hr after PEDIARIX, Hib, PCV7, ROTATEQ.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Dyspnoea, Feeling hot, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 1/21/09 pm fever, hot to touch, pain at injection site, shortness of breath, redness and swelling at injection site.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Pyrexia
Clinical narrative: 1/21/09 pm fever, hot to touch, pain at injection site, shortness of breath, redness and swelling at injection site.
Age: 0.6
Sex: F
Vaccine: TDAP
Symptoms: Wrong drug administered
Clinical narrative: Given TDAP instead of DTAP
Age: 0.6
Sex: F
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: fever, seizure like activity
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Fall, Nervousness, Pallor
Clinical narrative: Gave vaccines, pt. was nervous, I left the room so pt. could get dressed.  MOP said pt. got up to change and pt. fell back.  Pt. was pale.  We laid her down in the bed, gave her water and checked vitals.  Was checked by physician after and was cleared to go home.  Ok.
Age: 1.1
Sex: M
Vaccine: FLU3, HEPA, MMR, PNC
Symptoms: Measles, Pyrexia, Rash
Clinical narrative: patient received vaccines on 1-16-09- Hepatitis A, PREVNAR, influenza, and MMR. On 1-24-09 patient started with symptoms of rash, fever-rash started on face moving downward. (+) Koplik spots.
Age: 5.0
Sex: F
Vaccine: DTAPIPVHIB, HEP, MMR, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Upper arm with erythema, length of deltoid positive warmth, positive swelling given 10 days KEFLEX 250 mg every 12.
Age: 1.3
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Body temperature increased, Streptococcal identification test, Streptococcal identification test negative
Clinical narrative: high temp 103.5 degree F X 48 degree +  MOTRIN/TYLENOL
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Inflammation
Clinical narrative: Local inflammatory reaction to right upper arm
Age: 1.3
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Immediate post-injection reaction, Injection site rash, Intercostal retraction, Rash
Clinical narrative: Pt had an onset of facial rash & rash @ sites of vaccines within minutes post VARIVAX @ 1205- refractions was noticed.  1/1000 EPI 0.1 ml given in pt left arm.  EMS was called
Age: 1.3
Sex: M
Vaccine: DTAP, HEP, HEPA, HIBV, MMR, VARCEL
Symptoms: Computerised tomogram abnormal, Convulsion, Laboratory test, Pyrexia, Urine analysis
Clinical narrative: Seizure with fever - suspicious CT
Age: 18.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Rash
Clinical narrative: Reported rash on (R) side of face and on arm. Last for 3 days.
Age: 18.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site erythema, Injection site rash, No reaction on previous exposure to drug, Rash, Rash erythematous
Clinical narrative: Reported rash on (R) side of face and on arm. Last for 3 days.
Age: 1.2
Sex: M
Vaccine: FLU3, HEPA, HIBV, IPV, MMR, PNC, VARCEL
Symptoms: Herpes zoster, Skin lesion
Clinical narrative: Shingles- TX: BENADRYL TYLENOL Topical treatment of lesions
Age: 65.0
Sex: F
Vaccine: HEPAB, MMR, TDAP, VARCEL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Administered vaccine to patient. Patient older than eligible age. Product guidelines say age less than 65 yrs old is eligible. Client is 65 yrs old.
Age: 34.0
Sex: F
Vaccine: FLUN3
Symptoms: Angiogram, Antinuclear antibody, Electromyogram, Glossodynia, Hypoaesthesia
Clinical narrative: Numbness in right thumb that rapidly spread to both hands and then into feet. Sense of tongue burning followed by a sense of numbness about the face. Stiffness of legs. Mild saddle area paresthesias. Patient was 1st evaluated on 12/23/08 and c/o symptoms x 1-2 weeks. Patient states 1/26/08 symptoms almost and completely resolved.
Age: 34.0
Sex: F
Vaccine: FLUN3
Symptoms: Hypoaesthesia facial, Musculoskeletal stiffness, Nuclear magnetic resonance imaging, Paraesthesia, Pregnancy test
Clinical narrative: Numbness in right thumb that rapidly spread to both hands and then into feet. Sense of tongue burning followed by a sense of numbness about the face. Stiffness of legs. Mild saddle area paresthesias. Patient was 1st evaluated on 12/23/08 and c/o symptoms x 1-2 weeks. Patient states 1/26/08 symptoms almost and completely resolved.
Age: 34.0
Sex: F
Vaccine: FLUN3
Symptoms: Red blood cell sedimentation rate, Vitamin B12
Clinical narrative: Numbness in right thumb that rapidly spread to both hands and then into feet. Sense of tongue burning followed by a sense of numbness about the face. Stiffness of legs. Mild saddle area paresthesias. Patient was 1st evaluated on 12/23/08 and c/o symptoms x 1-2 weeks. Patient states 1/26/08 symptoms almost and completely resolved.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Presyncope
Clinical narrative: Pt had brief near syncopal episode when she got up from exam table, less than 2 minutes after injection. Completely resolved in 10 minutes. Did not completely lose consciousness.
Age: 16.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Asthenia, Dyspnoea, Headache, Pain in extremity, Pyrexia
Clinical narrative: Vomited x 2 since midnight. Fever to 102.2 with blurred vision short term. Headache. SOB from a few hours after shot until midnight. (L) arm soreness. Feels weak.
Age: 16.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Vision blurred, Vomiting
Clinical narrative: Vomited x 2 since midnight. Fever to 102.2 with blurred vision short term. Headache. SOB from a few hours after shot until midnight. (L) arm soreness. Feels weak.
Age: 0.4
Sex: F
Vaccine: DTAPIPVHIB, FLU3, PNC
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Influenza vaccine given to child less than 6 months of age.
Age: 74.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Skin plaque
Clinical narrative: Erythematous, tender to palpitation. Anterior aspect of left arm. Plaque about 4cm in diameter.
Age: 62.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Fatigue, Headache, Injection site pain, Nausea
Clinical narrative: Tired, chills, nausea, sore at inj site H/A, achy feeling.
Age: 62.0
Sex: F
Vaccine: TDAP
Symptoms: Pain
Clinical narrative: Tired, chills, nausea, sore at inj site H/A, achy feeling.
Age: 58.0
Sex: F
Vaccine: TDAP
Symptoms: Cellulitis, Ultrasound scan
Clinical narrative: Positive local cellulitis (L) deltoid treated with antibiotics.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site induration, Injection site swelling, Pain in extremity
Clinical narrative: Received ZOSTAVAX 1/27/09. 1/30/09 presented to our office arm pain from elbow to arm pit, "feels on fire" swollen, hard and red. Treated with OTC BENADRYL, Ibuprofen, Cephalexin and warm compresses.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Redness, tenderness, and warmth at site of injection possible infection --> pt. referred to PCP.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Local reaction, Musculoskeletal pain
Clinical narrative: Site of immunization red, swollen, tender with patient c/o arm, shoulder and neck pain - 1st local reaction I've seen with.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Site of immunization red, swollen, tender with patient c/o arm, shoulder and neck pain - 1st local reaction I've seen with.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: Since receiving Tdap pt. had fever, vomiting and body aches for 3 days.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Injection site pruritus, Malaise
Clinical narrative: Redness, edema, itchiness @ site of injection, c/o general malaise.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: Itchy. Red - warm area 2 days and gradually subsiding.
Age: 12.0
Sex: F
Vaccine: HEPA, TDAP, VARCEL
Symptoms: Dizziness, Syncope
Clinical narrative: Became dizzy while walking , fainted.
Age: 9.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Dizziness, Palpitations
Clinical narrative: Light headed, heart racing, palpitations.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Diarrhoea
Clinical narrative: Parent states the child had diarrhea x 7 days.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: 2/2/09 TC from client states "upper right arm has been hurting since she received the hepatitis A-B vaccine on 1/12/09". She has applied cold and heat, no discoloration noted, no warmth or redness but c/o pain, no decrease in ROM, no numbness reported by client. Still has sore arm.
Age: 2.0
Sex: F
Vaccine: FLU3, HEPA, PNC
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Patient with swelling, induration, warmth and ,mild erythema of left thigh.
Age: 17.0
Sex: F
Vaccine: DTAP, HPV4
Symptoms: Fall, Full blood count, Head injury, Metabolic function test, Scan brain
Clinical narrative: Pt had syncope within 3 min, fell to floor, hit head.  Unresponsive for several minutes.  VS were stable.  Went to ER for eval.  Recovered, sent home.
Age: 17.0
Sex: F
Vaccine: DTAP, HPV4
Symptoms: Syncope, Unresponsive to stimuli, Urine analysis
Clinical narrative: Pt had syncope within 3 min, fell to floor, hit head.  Unresponsive for several minutes.  VS were stable.  Went to ER for eval.  Recovered, sent home.
Sex: U
Vaccine: MMRV
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning his child who on an unspecified date was vaccinated with a dose of PROQUAD (lot number, injection site and route not reported). Subsequently the patient became autistic. It was unknown if the patient sought any medical attention. The outcome of the patient's experience was unknown. The consumer stated that PROQUAD caused his child become autistic. Upon internal review, became autistic was considered to be an other important medical event. No further information is available.
Sex: U
Vaccine: RV5
Symptoms: Haematochezia
Clinical narrative: Information has been received from a physician concerning a patient who on third week of December 2008 was vaccinated with the first dose of ROTATEQ (LOT# not reported). 24-28 hours after dose was given, the patient experienced blood in stools. The outcome of adverse event was unknown. The patient did not plan on administering any further doses. It was reported that the patient sought unspecified medical attention. The blood in stools was considered as important medical event. Additional information has been requested.
Age: 33.0
Sex: M
Vaccine: HEPA
Symptoms: Dysphagia, Dyspnoea, Hepatitis B antibody, Pain in extremity, Paraesthesia
Clinical narrative: 2/2/09 11 PM Tongue "thick and hard". Difficulty breathing and swallowing. 2/3/09 12 Noon (L) arm sore. (L) hand/fingers tingling. 2/3/09 Family called "doctor". Advised swallowing H2O. 2/6/09 All symptoms resolved.
Age: 33.0
Sex: M
Vaccine: HEPA
Symptoms: Paraesthesia oral, Tenderness, Tongue disorder
Clinical narrative: 2/2/09 11 PM Tongue "thick and hard". Difficulty breathing and swallowing. 2/3/09 12 Noon (L) arm sore. (L) hand/fingers tingling. 2/3/09 Family called "doctor". Advised swallowing H2O. 2/6/09 All symptoms resolved.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial pain, Herpes virus infection, Neck pain, Pain in extremity
Clinical narrative: Received ZOSTAVAX - on 9/17/08 in left upper deltoid. On 12/19/08, pain in left arm, left neck, left cheek occurred. Herpes lesions occurred - left nostril. Dr ordered VALTREX 1 gm TID - 10 days and pain meds.
Age: 1.9
Sex: M
Vaccine: FLU3
Symptoms: Ataxia
Clinical narrative: Ataxic gait on 12/3/08,  Flu vaccine 11/17. 3/19/09 MR received from PCP which include neuro consults.  Pt seen 11/17/08 for URI sx. Flu vax given. TC from parent 12/5/08 reporting child's balance is off, falling alot x 4 days. No other sx. Seen 12/6/08. PE (+) for clumsy gait, otherwise WNL. To observe. Assessment:  Clumsiness. Seen in neuro consult 12/9 and 12/12/08.  PE (+) for wide-based ataxic gait and increased muscle tone in extremities. DX:  Likely post-infectious cerebellitis. ? oposclonus-myoclonus ataxia syndrome. Improving by 12/30/08 but some intermittent hand tremulousness noted by parent. Final dx:  cerebellar ataxia.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Patient developed sore right arm the day she received the vaccine. Bothers her most at night rolling over in bed. Difficult to put deodorant on. No fever or redness.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain, Rash, Rash papular, Rash pruritic
Clinical narrative: Pt. received ZOSTAVAX on 01/06/2009. She developed an itchy painful rash on her neck and on itchy sensitive area right scapula and under her right breast on 02/01/2009. T: 96.3. B/P 130/70. P: 74 and regular red papules on back. No lesion seen on trunk. Pt. treated with Acyclovir 300 mg 5 times a day for 7 days. Report made to Vaccine Adverse Event Reporting System via internet site Vaers. org.
Age: 0.8
Sex: F
Vaccine: HEP
Symptoms: Urticaria
Clinical narrative: Pt developed urticaria (Hives) within 24 hours of receiving vaccine (HEP B)
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV
Symptoms: Crying, Pallor, Somnolence
Clinical narrative: Vaccine @ approx 2 pm, slept for 6 hours (unusual) waking once to nurse and cry @ 6 pm and then back to sleep until 8 pm. Upon waking went very pale (as white as paper) for about 15 minutes. He looked around during this time but would not smile and stayed very still. We called doc, he said possible pain reaction??? Happened again for about 2 minutes the following day.